These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23394753)

  • 1. RSV--a substantial slice of the airway disease burden and the way to a vaccine.
    Weigl JA
    Paediatr Int Child Health; 2012 Nov; 32 Suppl 2():S9-15. PubMed ID: 23394753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.
    Stockman LJ; Curns AT; Anderson LJ; Fischer-Langley G
    Pediatr Infect Dis J; 2012 Jan; 31(1):5-9. PubMed ID: 21817948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
    Munoz FM
    Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of respiratory syncytial virus vaccine development.
    Polack FP; Karron RA
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S65-73. PubMed ID: 14730272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies.
    Ali A; Yousafzai MT; Waris R; Jafri F; Aziz F; Abbasi IN; Zaidi A
    J Med Virol; 2017 Jul; 89(7):1151-1157. PubMed ID: 28092107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies for control of respiratory syncytial virus infection.
    Nokes JD; Cane PA
    Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan.
    Kaneko M; Watanabe J; Kuwahara M; Ueno E; Hida M; Kinoshita A; Sone T
    J Infect; 2002 May; 44(4):240-3. PubMed ID: 12099731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does respiratory virus coinfection increases the clinical severity of acute respiratory infection among children infected with respiratory syncytial virus?
    Harada Y; Kinoshita F; Yoshida LM; Minh le N; Suzuki M; Morimoto K; Toku Y; Tomimasu K; Moriuchi H; Ariyoshi K
    Pediatr Infect Dis J; 2013 May; 32(5):441-5. PubMed ID: 23838658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational sciences approach to RSV vaccine development.
    Kurzweil V; Tang R; Galinski M; Wang K; Zuo F; Cherukuri A; Gasser RA; Malkin E; Sifakis F; Mendel DB; Esser MT
    Expert Rev Vaccines; 2013 Sep; 12(9):1047-60. PubMed ID: 24053398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with respiratory syncytial virus vaccines.
    Piedra PA
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S94-9. PubMed ID: 12671459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.
    Jorquera PA; Anderson L; Tripp RA
    Expert Rev Vaccines; 2016; 15(2):173-87. PubMed ID: 26641318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the development of subunit-based RSV vaccines.
    Jaberolansar N; Toth I; Young PR; Skwarczynski M
    Expert Rev Vaccines; 2016; 15(1):53-68. PubMed ID: 26506139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children.
    Ferolla FM; Hijano DR; Acosta PL; Rodríguez A; Dueñas K; Sancilio A; Barboza E; Caría A; Gago GF; Almeida RE; Castro L; Pozzolo C; Martínez MV; Grimaldi LA; Rebec B; Calvo M; Henrichsen J; Nocito C; González M; Barbero G; Losada JV; Caballero MT; Zurankovas V; Raggio M; Schavlovsky G; Kobylarz A; Wimmenauer V; Bugna J; Williams JV; Sastre G; Flamenco E; Pérez AR; Ferrero F; Libster R; Grijalva CG; Polack FP
    Am J Respir Crit Care Med; 2013 May; 187(9):983-90. PubMed ID: 23449690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between respiratory syncytial virus (RSV) test data and hospitalization of children for RSV lower respiratory tract illness in Florida.
    Light M; Bauman J; Mavunda K; Malinoski F; Eggleston M
    Pediatr Infect Dis J; 2008 Jun; 27(6):512-8. PubMed ID: 18449062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria.
    Resch B; Sommer C; Nuijten MJ; Seidinger S; Walter E; Schoellbauer V; Mueller WD
    Pediatr Infect Dis J; 2012 Jan; 31(1):e1-8. PubMed ID: 21960187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive and active immunization against respiratory syncytial virus for the young and old.
    Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in developing a pediatric RSV vaccine.
    Schickli JH; Dubovsky F; Tang RS
    Hum Vaccin; 2009 Sep; 5(9):582-91. PubMed ID: 19556888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands.
    Meijboom MJ; Rozenbaum MH; Benedictus A; Luytjes W; Kneyber MC; Wilschut JC; Hak E; Postma MJ
    Vaccine; 2012 Jun; 30(31):4691-700. PubMed ID: 22561315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.